Kevin Balthaser - Sep 6, 2023 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
ACRS
Transactions as of
Sep 6, 2023
Transactions value $
$74,971
Form type
4
Date filed
9/7/2023, 04:16 PM
Previous filing
Sep 5, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Purchase $75K +9.49K +158.93% $7.90 15.5K Sep 6, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.